跳至主要内容
临床试验/KCT0001872
KCT0001872
招募中
未知

The development of predictive model for complete virologic response in chronic hepatitis B treated by antiviral drugs

Catholic Kwandong University International St.Mary's Hospital0 个研究点目标入组 82 人待定

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Diseases of the digestive system
发起方
Catholic Kwandong University International St.Mary's Hospital
入组人数
82
状态
招募中
最后更新
7年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
7年前
研究类型
Observational Study
性别
All

研究者

发起方
Catholic Kwandong University International St.Mary's Hospital

入排标准

入选标准

  • 1\)The patients who visited St. International Mary's hospital, Catholic Kwandong University College of Medicine and diagnosed as chronic hepatitis B
  • 2\)more than 20 years old men or women
  • 3\)The patients who do not receive anti\-viral agents for chronic hepatitis B before the clinical study.
  • 4\)The patients with chronic hepatitis B who was treated by tenofovir as an initial therapy
  • 5\)When tenofovir is required for the treatment of chronic hepatitis B and the condition of patients meet the selection criteria of the clinical study, we will ask for patient's absolute commitment. Then, we will select them as subjects after the agreement.

排除标准

  • 1\) The patients infected by chronic hepatitis C, hepatitis D or human immunodeficiency virus
  • 2\) a pregnant or breast\-feeding women or the pregnancy was confirmed by pregnancy test using serum or urine. The womeen who are planning to be pregnant during the clinical study or do not follow the approved contraceptive method.
  • 3\) the patients who were diagnosed as hepatocellular carcinoma or suspected as hepatocellular carcinoma through the examination of radiologic test or serum alphafeto\-protein.
  • 4\) The patients with other liver disease (hematochromatosis, Wilson diseasee, Alcoholic liver disease, Non\-alcoholic liver disteatosis, alpha\-1 antitrypsin deficiency
  • 5\) The patients who have a history of hypersensitivity reaction for the medicinne or the contents of clinical study
  • 6\) The patients who joined other clinical study 60 days before they are registered in the current study.
  • 7\) When clinicians judge the clinical study participation is determined as unfit subjects

结局指标

主要结局

未指定

相似试验